Uiterwaal C S, Witteman J C, van Stiphout W A, Krauss X H, de Bruijn A M, Hofman A, Grobbee D E
Department of Epidemiology & Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Atherosclerosis. 1996 May;122(2):235-44. doi: 10.1016/0021-9150(95)05758-7.
The aim of this study was to assess the predictive value of lipoproteins and apolipoproteins at a young age for the development of coronary artery disease at middle and older ages. Because children of coronary artery disease patients are at high risk themselves we compared lipoprotein and apolipoprotein levels between the offspring of parents with and without coronary artery disease. We selected a group of male patients (n = 90), who had severe coronary atherosclerosis at angiography, and a reference group of male controls (n = 62), who had no coronary atherosclerosis at angiography. Lipoprotein and apolipoprotein levels were determined in 115 sons and 73 daughters of the patients with severe coronary atherosclerosis. These were compared to levels in 68 sons and 47 daughters of controls. Additionally, lipoprotein and apolipoprotein levels were compared between patients and controls as well as between their spouses. In sons of patients, lower levels of HDL3 cholesterol (-0.07 mmol/1, standard error of the mean (SEM) 0.03, P < 0.05) and apolipoprotein A2 (-5.1 mg/dl (SEM, 1.4), P < 0.0001) were found compared to sons of controls. Similar differences were observed in daughters of such patients without, however, achieving statistical significance. No significant differences between the groups of offspring were found for total cholesterol, LDL cholesterol, HDL and HDL2 cholesterol, triglycerides and apolipoproteins A-I and B. Patients had higher levels of total (group difference 0.6 mmol/1 (SEM, 0.18), P < 0.001) and LDL cholesterol (0.6 mmol/1 (SEM, 0.17), P < 0.001), triglycerides (0.6 mmol/1 (SEM, 0.16), P < 0.001) and apolipoprotein B (21.2 mg/dl (SEM, 5.1), P < 0.001), and lower HDL cholesterol (0.1 mmol/1 (SEM, 0.04), P < 0.05) than controls. Spouses of patients had higher levels of triglycerides (0.23 mmol/1 (SEM, 0.11), P < 0.05). Our findings add to the growing evidence that predictors for atherosclerotic disease can be detected relatively early in life. It is concluded that reduced levels of HDL3 cholesterol and apolipoprotein A2 may be early risk indicators for coronary atherosclerosis later in life.
本研究的目的是评估年轻时脂蛋白和载脂蛋白对中老年期冠状动脉疾病发生的预测价值。由于冠状动脉疾病患者的子女自身处于高风险中,我们比较了有和没有冠状动脉疾病的父母的后代之间的脂蛋白和载脂蛋白水平。我们选择了一组男性患者(n = 90),他们在血管造影时患有严重冠状动脉粥样硬化,以及一组男性对照组(n = 62),他们在血管造影时没有冠状动脉粥样硬化。测定了115名患有严重冠状动脉粥样硬化患者的儿子和73名女儿的脂蛋白和载脂蛋白水平。将这些水平与68名对照组儿子和47名对照组女儿的水平进行比较。此外,还比较了患者与对照组之间以及他们配偶之间的脂蛋白和载脂蛋白水平。在患者的儿子中,与对照组的儿子相比,发现HDL3胆固醇水平较低(-0.07 mmol/1,平均标准误差(SEM)0.03, P < 0.05)和载脂蛋白A2较低(-5.1 mg/dl(SEM,1.4),P < 0.0001)。在这些患者的女儿中也观察到了类似的差异,然而,未达到统计学显著性。在后代组之间,总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白和高密度脂蛋白2胆固醇、甘油三酯以及载脂蛋白A-I和B没有发现显著差异。患者的总胆固醇(组间差异0.6 mmol/1(SEM,0.18),P < 0.001)、低密度脂蛋白胆固醇(0.6 mmol/1(SEM,0.17),P < 0.001)、甘油三酯(0.6 mmol/1(SEM,0.16),P < 0.001)和载脂蛋白B(21.2 mg/dl(SEM,5.1),P < 0.001)水平较高,而高密度脂蛋白胆固醇(0.1 mmol/1(SEM,0.04),P < 0.05)水平低于对照组。患者的配偶甘油三酯水平较高(0.23 mmol/1(SEM,0.11),P < 0.05)。我们的研究结果进一步证明了越来越多的证据表明,动脉粥样硬化疾病的预测指标可以在生命早期相对较早地被检测到。得出的结论是,HDL3胆固醇和载脂蛋白A2水平降低可能是晚年冠状动脉粥样硬化的早期风险指标。